Guardant Health Inc (NASDAQ: GH) is 37.25% higher on its value in year-to-date trading and has touched a low of $18.01 and a high of $52.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $44.05 in the last trading session, with the day’s loss setting it -2.12%.
Currently trading at $41.93, the stock is -7.12% and -4.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.05 million and changing -4.81% at the moment leaves the stock 21.07% off its SMA200. GH registered 129.63% gain for a year compared to 6-month gain of 91.64%.
The stock witnessed a 3.33% loss in the last 1 month and extending the period to 3 months gives it a -11.11%, and is -15.34% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.20% over the week and 7.41% over the month.
Guardant Health Inc (GH) has around 2021 employees, a market worth around $5.19B and $774.00M in sales. Profit margin for the company is -53.82%. Distance from 52-week low is 132.82% and -20.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.60%).
The EPS is expected to grow by 22.03% this year.
Guardant Health Inc (GH) Top Institutional Holders
The shares outstanding are 123.65M, and float is at 117.48M with Short Float at 6.48%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5035% of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.1777 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 4.9763% and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6751 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Talasaz AmirAli, the company’s Co-Chief Executive Officer. SEC filings show that Talasaz AmirAli sold 106,784 shares of the company’s common stock on May 01 ’25 at a price of $49.01 per share for a total of $5.23 million. Following the sale, the insider now owns 2.2 million shares.
Guardant Health Inc disclosed in a document filed with the SEC on May 02 ’25 that Talasaz AmirAli (Co-Chief Executive Officer) sold a total of 13,932 shares of the company’s common stock. The trade occurred on May 02 ’25 and was made at $50.47 per share for $0.7 million. Following the transaction, the insider now directly holds 2.19 million shares of the GH stock.
Still, SEC filings show that on May 01 ’25, Talasaz AmirAli (Officer) Proposed Sale 340,000 shares at an average price of $49.01 for $16.66 million. The insider now directly holds shares of Guardant Health Inc (GH).
